FDA grants Breakthrough Device Designation to Gene Solutions' SPOT-MAS 10 multi-cancer screening test
May 28, 2026 | 11:02
The U.S. Food and Drug Administration has awarded Breakthrough Device Designation to SPOT-MAS 10, the multi-cancer early detection test developed by Singapore-based Gene Solutions, marking a pivotal regulatory milestone for the company's push into the American oncology market.
Latest News
Mobile Version